About Exstent
The ExoVasc® PEARS was developed by Tal Golesworthy, an engineer with Marfan syndrome, to provide an alternative to aortic root replacement surgery.
Exstent aims to make a difference to the lives of people with aortic dilation. Our goal is to allow patients to live free from worry, without need for anticoagulant therapy and reduce the risk of requiring further surgery.
0
+
ExoVasc® PEARS patients since 2004